Protocol Page


	Study ID (Protocol Number)
	IM133-004


	STUDY LOCATIONS*
	Arthritis Associates Of Mississippi Jackson, MS 39202 Recruiting	East Penn Rheumatology Associates, P.C. Bethlehem, PA 18015 Recruiting
	Box Arthritis And Rheumatology Of The Carolinas, Pllc Charlotte, NC 28210 Recruiting	Health Research Of Oklahoma Oklahoma City, OK 73103 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy
	STUDY OVERVIEW
	The purpose of this study is to characterize the safety, efficacy and dose response of BMS-945429 in subjects with active Psoriatic Arthritis and an inadequate response to Nonsteroidal anti-inflammatory drugs (NSAIDs) and non-biologic Disease modifying anti-rheumatic drugs (DMARDs).

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.